Skip to main content

Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis

Publication ,  Journal Article
Whitticar, N; Nunemaker, C
Published in: The FASEB Journal
May 2022

Insulin is secreted from pancreatic islets in a pulsatile manner due to alternating periods of cellular activity and rest. The resulting pulses of insulin are critical for proper hormonal signaling and blood glucose regulation by the liver. To recreate the interaction between the endocrine pancreas and the liver using primary murine tissue, we have designed 3D printed microfluidic platforms that hold hepatocytes downstream of islets. Islets no longer oscillate in sync once isolated from the pancreas, so the cumulative insulin released is non‐pulsatile as demonstrated by taking the average intracellular calcium levels of multiple islets (Figure A, top). To force islets to secrete synchronized insulin pulses , we use programable syringe pumps that flow alternating high (11mM) and low (3mM) glucose solutions over isolated mouse islets. The syringe pump system aligns the oscillations which results in synchronized insulin release (Figure A, bottom). Next, we exposed primary murine hepatocytes to either 100nM pulses of insulin in three‐minute periods or constant 50nM insulin in a microfluidic system (Figure B). Both groups were exposed to the same amount of insulin, just in a different pattern. Hepatocytes treated with pulsatile insulin for 4 hours contained significantly more glycogen compared to those treated with continuous 50nM insulin (P<0.05, N=4). Future experiments will add hepatocytes downstream of the islets on the same platform to investigate the effect of pulsatile insulin and glucagon secretion on liver function. Exploring the interaction between pancreatic islets and hepatocytes will lead to a deeper understanding of the loss of pulsatile hormone secretion during the progression of type 2 diabetes.

Duke Scholars

Published In

The FASEB Journal

DOI

EISSN

1530-6860

ISSN

0892-6638

Publication Date

May 2022

Volume

36

Issue

S1

Publisher

Wiley

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3208 Medical physiology
  • 3101 Biochemistry and cell biology
  • 1116 Medical Physiology
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Whitticar, N., & Nunemaker, C. (2022). Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis. The FASEB Journal, 36(S1). https://doi.org/10.1096/fasebj.2022.36.s1.r6289
Whitticar, Nicholas, and Craig Nunemaker. “Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis.” The FASEB Journal 36, no. S1 (May 2022). https://doi.org/10.1096/fasebj.2022.36.s1.r6289.
Whitticar N, Nunemaker C. Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis. The FASEB Journal. 2022 May;36(S1).
Whitticar, Nicholas, and Craig Nunemaker. “Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis.” The FASEB Journal, vol. 36, no. S1, Wiley, May 2022. Crossref, doi:10.1096/fasebj.2022.36.s1.r6289.
Whitticar N, Nunemaker C. Developing an In Vitro Platform to Mimic the Pancreas‐Liver Endocrine Axis. The FASEB Journal. Wiley; 2022 May;36(S1).

Published In

The FASEB Journal

DOI

EISSN

1530-6860

ISSN

0892-6638

Publication Date

May 2022

Volume

36

Issue

S1

Publisher

Wiley

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3208 Medical physiology
  • 3101 Biochemistry and cell biology
  • 1116 Medical Physiology
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology